Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
FASN |
fatty acid synthase |
FXC00314
|
FHC00314
|
FNC00314N
|
FNC00314C
|
TSHR |
thyroid stimulating hormone receptor, transcript variant 1 |
FXC01753
|
FHC01753
|
FNC01753N
|
FNC01753C
|
IFNA16 |
interferon, alpha 16 |
FXC02322
|
FHC02322
|
FNC02322N
|
FNC02322C
|
IFNA1 |
interferon, alpha 1 |
FXC03299
|
FHC03299
|
FNC03299N
|
FNC03299C
|
ZNF395 |
zinc finger protein 395 |
FXC03445
|
FHC03445
|
FNC03445N
|
FNC03445C
|
FAS |
Fas cell surface death receptor |
FXC04988
|
FHC04988
|
FNC04988N
|
FNC04988C
|
IL10 |
interleukin 10 |
FXC07552
|
FHC07552
|
FNC07552N
|
FNC07552C
|
CHGA |
chromogranin A, transcript variant 1 |
FXC07948
|
FHC07948
|
FNC07948N
|
FNC07948C
|
HLA-DMA |
major histocompatibility complex, class II, DM alpha |
FXC08554
|
FHC08554
|
FNC08554N
|
FNC08554C
|
CD40 |
CD40 molecule, TNF receptor superfamily member 5, transcript variant 1 |
FXC08629
|
FHC08629
|
FNC08629N
|
FNC08629C
|
FASLG |
Fas ligand (TNF superfamily, member 6), transcript variant 1 |
FXC08901
|
FHC08901
|
FNC08901N
|
FNC08901C
|
ELF2 |
E74-like factor 2 (ets domain transcription factor), transcript variant 2 |
FXC09540
|
FHC09540
|
FNC09540N
|
FNC09540C
|
GZMB |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
FXC10250
|
FHC10250
|
FNC10250N
|
FNC10250C
|
CD86 |
CD86 molecule, transcript variant 1 |
FXC10363
|
FHC10363
|
FNC10363N
|
FNC10363C
|
HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3
|
FXC10549
|
FHC10549
|
|
|
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1, transcript variant 1 |
FXC10550
|
FHC10550
|
FNC10550N
|
FNC10550C
|
PRF1 |
perforin 1 (pore forming protein), transcript variant 1 |
FXC11041
|
FHC11041
|
FNC11041N
|
FNC11041C
|
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
FXC11450
|
FHC11450
|
FNC11450N
|
FNC11450C
|
SLC26A3 |
solute carrier family 26 (anion exchanger), member 3 |
FXC11726
|
FHC11726
|
FNC11726N
|
FNC11726C
|
CGA |
glycoprotein hormones, alpha polypeptide, transcript variant 2 |
FXC12142
|
FHC12142
|
FNC12142N
|
FNC12142C
|
TPO |
thyroid peroxidase |
FXC15889
|
FHC15889
|
FNC15889N
|
FNC15889C
|
IFNA13 |
interferon, alpha 13 |
FXC15894
|
FHC15894
|
FNC15894N
|
FNC15894C
|
TSHB |
thyroid stimulating hormone, beta, transcript variant 1 |
FXC20489
|
FHC20489
|
FNC20489N
|
FNC20489C
|
CD28 |
CD28 molecule, transcript variant 1 |
FXC21287
|
FHC21287
|
FNC21287N
|
FNC21287C
|
CTLA4 |
cytotoxic T-lymphocyte-associated protein 4, transcript variant 1 |
FXC21288
|
FHC21288
|
FNC21288N
|
FNC21288C
|
CD80 |
CD80 molecule |
FXC21656
|
FHC21656
|
FNC21656N
|
FNC21656C
|
THPO |
thrombopoietin, transcript variant 1 |
FXC21783
|
FHC21783
|
FNC21783N
|
FNC21783C
|
IFNA21 |
interferon, alpha 21 |
FXC23475
|
FHC23475
|
FNC23475N
|
FNC23475C
|
IFNA4 |
interferon, alpha 4 |
FXC23476
|
FHC23476
|
FNC23476N
|
FNC23476C
|
IFNA10 |
interferon, alpha 10 |
FXC23477
|
FHC23477
|
FNC23477N
|
FNC23477C
|
IFNA17 |
interferon, alpha 17 |
FXC23478
|
FHC23478
|
FNC23478N
|
FNC23478C
|
IFNA14 |
interferon, alpha 14 |
FXC23479
|
FHC23479
|
FNC23479N
|
FNC23479C
|
IFNA5 |
interferon, alpha 5 |
FXC23480
|
FHC23480
|
FNC23480N
|
FNC23480C
|
IFNA6 |
interferon, alpha 6 |
FXC23481
|
FHC23481
|
FNC23481N
|
FNC23481C
|
IFNA2 |
interferon, alpha 2 |
FXC23482
|
FHC23482
|
FNC23482N
|
FNC23482C
|
IFNA8 |
interferon, alpha 8 |
FXC23483
|
FHC23483
|
FNC23483N
|
FNC23483C
|
CD40LG |
CD40 ligand |
FXC27535
|
FHC27535
|
FNC27535N
|
FNC27535C
|
RBM45 |
RNA binding motif protein 45 |
FXC28752
|
FHC28752
|
FNC28752N
|
FNC28752C
|
IFNA7 |
interferon, alpha 7 |
FXC29362
|
FHC29362
|
FNC29362N
|
FNC29362C
|
IL2 |
interleukin 2 |
FXC31382
|
FHC31382
|
FNC31382N
|
FNC31382C
|
IL5 |
interleukin 5 |
FXC31397
|
FHC31397
|
FNC31397N
|
FNC31397C
|
IL4 |
interleukin 4, transcript variant 1 |
FXC31398
|
FHC31398
|
FNC31398N
|
FNC31398C
|